COMMUNICATIONS TO THE EDITOR

NA22598A15a Novel Antitumor Substance
Produced by Streptomyces sp. NA22598
Sir:
In the course of our screening program for new antitumor compounds, we isolated a new type of peptide, NA22598Ai (1) (Fig. 1 ) from a culture broth of Streptomyces sp. NA22598 (FERM P-14686) . This compoundproved to inhibit the anchorage-independent growth of a humancolon-cancer cell line, DLD-1, on poly 2-hydroxyethylmethacrylate (HEMA) coated plates1*. In this paper we report the production, isolation, physico-chemical properties and biological properties of 1.
The strain was cultured at 27°C for 5 days in 500-ml Erlenmeyer flasks containing 100ml of a medium composed ofgalactose 2.0%, dextrin 2.0%, corn steep liquor 0.5%, Bacto-soytone (Difco) 1.0%, (NH4)2SO4 0.2% and CaCO3 0.2%, adjusted to pH 7.4 before sterilization.
Isolation was followed by measuring the antitumor activity against the anchorage-independent growth of DLD-1 on poly HEMAcoated plates. The culture broth (20 liters) pH was adjusted to 4.0 with 6n HC1 and was allowed to stand at r.t. for an hour, and was centrifuged at 15,000rpm. The supernatant was applied to a Dowex 50Wx 2 (H+) column. The active fractions were eluted with 1.5N NH4OH after washing with water and the eluate was concentrated in vacuo for removing ammonia. The concentrated solution was applied to an Amberlite CG-50 (H+) column. The activity was eluted with 1.5n NH4OH and then the eluate was evaporated in vacuo to dryness. This residue was dissolved in water and applied to a TSK gel SP-Toyopearl 650C (NH£) column. After washing the column with water, the elution was carried out by a linear gradient from H2Oto 1.0m NH4C1. The active fractions were collected and then absorbed on a (1). AUG. 1997 Diaion SP-207 column for desalination. After washing the column with water, the activity was eluted with 50% aqueous acetone. The eluate was concentrated and was applied to a TSK gel SP-Toyopearl 650C (NH4 ) column which was pre-equilibrated with 0.05 m NH4OAcbuffer (pH 3.7) before use. The elution was carried out by a linear gradient from 0.05 to 1.00m NH4OAcbuffer (pH 3.7). The active fractions were eluted approximately at 0.6m NH4OAcbuffer, collected and desalinated as described above using Diaion SP-207. The active compounds were purified by a preparative HPLC (ODS, Capcell pak UG-120) using the mobile phase of 5% CH3CNin 50mMphosphate buffer (pH 9.2). The active fractions were collected and desalinated by a Dowex 50Wx8 (H+) column with 1.5n NH4OHelution. The eluate was finally concentrated and lyophilized to afford 20mg ofl.
NA22598AX (1) and valine units were elucidated. Analysis of HMBC spectra revealed the connectivities among units described above. The structure of NA22598A!is a unique peptide containing the l -carbamoyl-2-iminoimidazolin moiety3). Details of the structural determination of 1 and its congeners will be reported in a separate paper. NA22598AX was inactive at 200/xg/ml against Grampositive and Gram-negative bacteria, yeast and fungi.
NA22598AX
inhibited the anchorage-independent growth of DLD-1 cells on poly (HEMA)-coated plates at the concentration of0.32 fiM (IC50), but did not inhibit the growth on uncoated plates at the same concentration. This result suggests that NA22598AXmay be an inhibitor of oncogenic signal-transduction pathways4). Details of biological activity and the mechanismof action studies of NA22598Ai will be reported in a separated paper. 
